Andrea Bastek is the Director of Innovation at Florence, the largest eISF + Remote Site Access platform in clinical research with more than 8,000 study sites across 30 countries connected. She has extensive experience in the clinical trials space for medical devices, including deep collaboration with sites to drive processes that ensure successful study participation. She is committed to finding workflow efficiencies that improve clinical trial execution. She holds a Ph.D. in Biomedical Engineering from the Georgia Institute of Technology.
The industry needs to more clearly define the different competencies and career paths within clinical research so all employees can lean into their strengths and build a career plan that brings them fulfillment.
When patients can travel to a pharmacy or doctor’s office in their own neighborhood, they can reach the site on foot or using public transit. They also have to take less time off work and request childcare less often.
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.
Staffing shortages can slow down trial timelines and negatively affect patients, who have less time with the physicians and nurses providing their care. But a few flexible, integrated systems that work for both clinical research sites and sponsors could help alleviate these issues and speed up research.
ntegrated software, accessible genetic data, and advances in precision medicine can transform the lives of millions of patients–if the clinical trial and larger medical industry embrace these trends.
Technology can assist sponsors in setting up trials and activating clinical trial sites quickly. But tech will only play a small role within the larger movement toward accelerated approval.
Research organizations can participate in ethical data sharing today by considering participants’ privacy and security and balancing the need to protect their commercial interests with the need to share enough data to benefit medical research.
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.